Crohn's Disease and Colitis Trial, Recruiting NCT01140789 Sponsor: Chinese University of Hong Kong Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT01140789
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You (or a family member on your behalf) must agree to take part and sign a consent form
  • If you are in the patient group: you have been diagnosed with Crohn's disease or ulcerative colitis, confirmed through camera tests (endoscopy), imaging scans, and tissue samples
  • If you are in the comparison group: you are attending a clinic or having a camera test for non-inflammatory gut symptoms (such as functional digestive issues) or a routine bowel screening, and you will be matched by age and sex to the patient group

Who may not be able to join:

  • Anyone who does not agree to take part or does not sign the consent form cannot join
  • If you are in the comparison group, you cannot join if you have previously been diagnosed with Crohn's disease or ulcerative colitis
  • If you are in the comparison group, you cannot join if a close family member (parent, sibling, child, grandparent, aunt, uncle, or cousin) has been diagnosed with Crohn's disease or ulcerative colitis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Siew C NG, PhD, Chinese University of Hong Kong

Phone: +852 3505 3509

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2010
Est. completion
1 April 2037

Where this trial is recruiting

Hong Kong

Primary endpoints

To identify genetic variation among three study groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov